Tuesday, February 26, 2019
Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices | Kaiser Health News
Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices | Kaiser Health News: Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment